全文获取类型
收费全文 | 3385576篇 |
免费 | 251656篇 |
国内免费 | 5016篇 |
专业分类
耳鼻咽喉 | 47167篇 |
儿科学 | 111098篇 |
妇产科学 | 93832篇 |
基础医学 | 491710篇 |
口腔科学 | 96801篇 |
临床医学 | 305958篇 |
内科学 | 649201篇 |
皮肤病学 | 74112篇 |
神经病学 | 270127篇 |
特种医学 | 129201篇 |
外国民族医学 | 902篇 |
外科学 | 508921篇 |
综合类 | 76490篇 |
现状与发展 | 13篇 |
一般理论 | 1299篇 |
预防医学 | 267275篇 |
眼科学 | 79316篇 |
药学 | 253624篇 |
13篇 | |
中国医学 | 6359篇 |
肿瘤学 | 178829篇 |
出版年
2018年 | 35772篇 |
2017年 | 27245篇 |
2016年 | 30533篇 |
2015年 | 34721篇 |
2014年 | 48783篇 |
2013年 | 73904篇 |
2012年 | 101075篇 |
2011年 | 107341篇 |
2010年 | 63771篇 |
2009年 | 60480篇 |
2008年 | 101336篇 |
2007年 | 107746篇 |
2006年 | 108943篇 |
2005年 | 106001篇 |
2004年 | 102523篇 |
2003年 | 98202篇 |
2002年 | 95838篇 |
2001年 | 151203篇 |
2000年 | 155954篇 |
1999年 | 131878篇 |
1998年 | 38345篇 |
1997年 | 33979篇 |
1996年 | 33965篇 |
1995年 | 32494篇 |
1994年 | 30203篇 |
1993年 | 28512篇 |
1992年 | 105524篇 |
1991年 | 103172篇 |
1990年 | 100779篇 |
1989年 | 97393篇 |
1988年 | 90171篇 |
1987年 | 88527篇 |
1986年 | 83708篇 |
1985年 | 80628篇 |
1984年 | 60450篇 |
1983年 | 51847篇 |
1982年 | 30773篇 |
1981年 | 27747篇 |
1979年 | 56805篇 |
1978年 | 40222篇 |
1977年 | 33744篇 |
1976年 | 32147篇 |
1975年 | 34381篇 |
1974年 | 41601篇 |
1973年 | 39786篇 |
1972年 | 37135篇 |
1971年 | 35072篇 |
1970年 | 32345篇 |
1969年 | 30732篇 |
1968年 | 28097篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
951.
Formoterol, a new long acting beta 2 agonist for inhalation twice daily, compared with salbutamol in the treatment of asthma. 总被引:5,自引:2,他引:3 下载免费PDF全文
Sixteen patients with stable chronic asthma participated in a double blind crossover study comparing the new inhaled long acting beta 2 agonist formoterol with salbutamol. Inhaled (n = 15) and oral steroid (n = 1) treatment were maintained at the same daily dose throughout the study. For four weeks the patients received either formoterol 24 micrograms twice daily or salbutamol 400 micrograms twice daily, plus additional puffs (with the same drug) when needed. Asthma symptoms, additional puffs of beta 2 agonist, peak expiratory flow (PEF), and side effects were recorded daily. During treatment with formoterol the patients used fewer additional puffs of beta 2 agonist, had better symptom scores, less disturbed sleep, more days without additional aerosol, and higher PEF both morning and evening than during salbutamol treatment. Thus formoterol 24 micrograms twice daily gave long lasting bronchodilatation and asthma symptoms were well controlled with regular twice daily administration. 相似文献
952.
953.
954.
Extravesical versus Leadbetter-Politano ureteroneocystostomy: a comparison of urological complications in 320 renal transplants 总被引:3,自引:0,他引:3
The urological complications of 320 consecutive renal transplants performed at our institution between October 17, 1985 and November 10, 1989 are reviewed. The Leadbetter-Politano technique of ureteroneocystostomy was used in the first 160 patients (group 1) and an anterior extravesical technique modified from the methods of Witzel, Sampson and Lich was performed in the second 160 patients (group 2). Urological complications occurred in 15 patients (9.4%) in group 1 and 6 (3.7%) in group 2 (p = 0.04). Ureterovesical junction obstruction occurred in 6 patients (3.7%) in group 1 and 1 (0.6%) in group 2 (p = 0.05). Complications of leakage, ureteral necrosis and ureteral stricture were comparable in the 2 groups. Therefore, we advocate the use of the anterior extravesical technique over Leadbetter-Politano ureteral reimplantation based on the lower incidence of urological complications and various technical advantages, including less operative time, avoidance of a separate cystotomy, less hematuria and ability to use short donor ureters. 相似文献
955.
956.
957.
Improved graft survival for flow cytometry and antihuman globulin crossmatch-negative retransplant recipients 总被引:1,自引:0,他引:1
R H Kerman C T Van Buren R M Lewis V DeVera V Baghdahsarian K Gerolami B D Kahan 《Transplantation》1990,49(1):52-56
We compared our standard NIH (extended incubation) crossmatch (XM) with antihuman globulin (AHG) and flow cytometry XMs and correlated the results with rejection episodes and graft survivals. For 89 CsA-Pred, primary renal allograft recipients, AHG and/or FCXM results did not improve on the NIH-XM-negative (NEG) graft survival results, whether testing pretransplant or historical (Hx) sera. Similarly, there was no association of a positive (POS) AHG or FCXM with increased rejection episodes in these primary recipients. However, for retransplant (Re-Tx) recipients a neg AHG or FCXM did discriminate fewer rejections and an improved graft survival compared with the NIH-XM-neg. results. The overall one-year graft survival for the 47 Re-Tx recipients studied herein was 66% (based on a neg pre-Tx NIH-XM). Pre-Tx AHG-NEG, Re-Tx recipients displayed an improved graft survival compared with NIH-XM NEG recipients (77% vs. 66%, P less than 0.05) and with AHG-POS recipients (77% vs. 47%, P less than 0.05). Similarly, pre-Tx, FCXM-NEG, Re-Tx recipients displayed improved graft survivals compared with NIH-XM-NEG recipients (83% vs. 66%, P less than 0.05) and FCXM-POS recipients (83% vs. 48%, P less than 0.05). Re-Tx recipients displaying a POS AHG and/or FCXM experienced a significantly greater number of rejections than NEG-XM recipients (P less than 0.05, respectively). The AHG and FCXM results correlated with rejections and graft survivals whether testing pre-Tx or Hx high-PRA sera. Re-Tx recipients who were AHG-XM-NEG but FCXM-POS, experienced more rejection episodes than recipients who displayed a negative XM reactivity for both AHG and FCXM (P less than 0.02), but with no resulting differences in graft survival. HLA matching, pre-Tx blood transfusions and PRA did not impact on these crossmatch and graft survival results. Use of AHG and/or FCXMs for Re-Tx, but not primary, recipients should help to improve graft survival for these high-risk recipients. 相似文献
958.
P A Lear 《Transplantation proceedings》1990,22(6):2441-2442
959.
A distinctive cardiovascular lesion resembling histiocytoid (epithelioid) hemangioma. Evidence suggesting mesothelial participation 总被引:1,自引:0,他引:1
D J Luthringer R Virmani S W Weiss J Rosai 《The American journal of surgical pathology》1990,14(11):993-1000
This paper presents 14 examples of a distinctive cardiovascular lesion. The patients' ages ranged from 5 to 76 years (mean, 51 years). There were seven male patients and seven female patients. All of the lesions were small and represented incidental surgical findings. Ten were attached to the endocardium, three were free-floating in the pericardial cavity, and one was inside a dissecting aneurysm of the ascending aorta. Microscopically, the lesions were enclosed in a fibrinous network and composed of a solid proliferation of round to polygonal cells with centrally located nuclei. Immunohistochemically, the cells were negative for FVIII-related antigen and lysozyme, but they stained positively for keratin, especially when clustered in small micropapillary or tubule-like formations. The nature and pathogenesis of these lesions are uncertain. Their location and some of their microscopic features originally suggested a relationship with the entity described as histiocytoid (epithelioid) hemangioma. However, their intense immunoreactivity for keratin, occasional presentation in the pericardial sac, and marked morphologic similarities with nodular mesothelial hyperplasia as sometimes seen in hernia sacs point toward the alternative possibility of a reactive mesothelial nature. A possible pathogenetic mechanism for the endocardial cases is ingrowth of pericardial mesothelial cells along a perforation tract that may have developed at the time of a cardiac catheterization. There were no recurrences or metastases in any of the cases. 相似文献
960.